These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33571033)

  • 1.
    Hamill Skoch S; Mills JA; Ramsey L; Strawn JR
    J Child Adolesc Psychopharmacol; 2021 Jun; 31(5):387-388. PubMed ID: 33571033
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder.
    Fineberg NA; Pampaloni I; Pallanti S; Ipser J; Stein DJ
    Int Clin Psychopharmacol; 2007 Nov; 22(6):313-22. PubMed ID: 17917549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic management of obsessive-compulsive disorder.
    Jackson CW; Morton WA; Lydiard RB
    South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder.
    Besiroglu L; Çetinkaya N; Selvi Y; Atli A
    Compr Psychiatry; 2011; 52(5):556-61. PubMed ID: 21109243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
    Bergeron R; Ravindran AV; Chaput Y; Goldner E; Swinson R; van Ameringen MA; Austin C; Hadrava V
    J Clin Psychopharmacol; 2002 Apr; 22(2):148-54. PubMed ID: 11910259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
    Prescrire Int; 2000 Aug; 9(48):112-3. PubMed ID: 11067720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    Maina G; Albert U; Salvi V; Bogetto F
    J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review.
    Murphy TK; Bengtson MA; Tan JY; Carbonell E; Levin GM
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S47-63. PubMed ID: 11110019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxetine and its uses in psychiatry.
    Bell C; Nutt D
    Hosp Med; 1999 May; 60(5):353-6. PubMed ID: 10396411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sertraline in child and adolescent psychiatry].
    Voloshina VM; Kashnikova AA; Tatarova IN; Kim LV; Koren' EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(8):25-8. PubMed ID: 11552629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders?
    Safer DJ
    Pediatrics; 2006 Sep; 118(3):1248-51. PubMed ID: 16951019
    [No Abstract]   [Full Text] [Related]  

  • 12. An evidence-based review of the clinical use of sertraline in mood and anxiety disorders.
    Sheehan DV; Kamijima K
    Int Clin Psychopharmacol; 2009 Mar; 24(2):43-60. PubMed ID: 21456103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with adjunctive N-acetylcysteine in an adolescent with selective serotonin reuptake inhibitor-resistant anxiety.
    Strawn JR; Saldaña SN
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):472-3. PubMed ID: 23234593
    [No Abstract]   [Full Text] [Related]  

  • 14. Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies.
    Feiger AD; Flament MF; Boyer P; Gillespie JA
    Int Clin Psychopharmacol; 2003 Jul; 18(4):203-10. PubMed ID: 12817154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing of selective serotonin reuptake inhibitors, anxiolytics, and sedative-hypnotics by general practitioners in The Netherlands: a multivariate analysis.
    Pathiyal A; Hylan TR; Jones JK; Davtian D; Sverdlov L; Keyser M
    Clin Ther; 1997; 19(4):798-810. PubMed ID: 9377622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fluoxetine concentrations and clinical improvement in an adolescent sample diagnosed with major depressive disorder, obsessive-compulsive disorder, or generalized anxiety disorder.
    Blázquez A; Mas S; Plana MT; Gassó P; Méndez I; Torra M; Arnaiz JA; Lafuente A; Lázaro L
    J Clin Psychopharmacol; 2014 Jun; 34(3):318-26. PubMed ID: 24743718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are paroxetine, fluoxetine, and sertraline equally effective for depression?
    Straton JB; Cronholm P
    J Fam Pract; 2002 Mar; 51(3):285. PubMed ID: 11978244
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of selective serotonin reuptake inhibitor treatment in children and adolescents].
    Bailly D
    Presse Med; 2006 Sep; 35(9 Pt 2):1293-302. PubMed ID: 16969324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertraline and tic: case report.
    Ghanizadeh A
    Pharmacopsychiatry; 2007 Nov; 40(6):289-90. PubMed ID: 18030654
    [No Abstract]   [Full Text] [Related]  

  • 20. Sleep-Related Problems and the Effects of Anxiety Treatment in Children and Adolescents.
    Caporino NE; Read KL; Shiffrin N; Settipani C; Kendall PC; Compton SN; Sherrill J; Piacentini J; Walkup J; Ginsburg G; Keeton C; Birmaher B; Sakolsky D; Gosch E; Albano AM
    J Clin Child Adolesc Psychol; 2017; 46(5):675-685. PubMed ID: 26467211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.